Ono type DX Breast Recurrence Score Test
- Buyer
- Leeds Teaching Hospitals NHS Trust
- Published
- 2026-10-26
- Deadline
- 2026-06-30T11:00:00+00:00
- Sources
- UK_CF
- Value
- 405000.0 GBP
Description
The description is in the source language.
Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.
CPV: 85111800
Membership
Read notice previews free of charge. Official notice and document links, construction permits and personal MCP access require an active paid membership.
Read